These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2642566)

  • 1. Controlled clinical trial of adjuvant immunotherapy with BCG and neuraminidase-treated autologous tumour cells in large bowel cancer.
    Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
    J Surg Oncol; 1989 Jan; 40(1):34-7. PubMed ID: 2642566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melbourne trial of adjuvant immunotherapy in operable large bowel cancer.
    Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
    Aust N Z J Surg; 1988 Jan; 58(1):43-6. PubMed ID: 3046593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: a 7-year follow-up analysis.
    Abdi EA; Hanson J; Harbora DE; Young DG; McPherson TA
    J Surg Oncol; 1989 Mar; 40(3):205-13. PubMed ID: 2645466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV; McKhann CF; Grage TB; Gunnarsson A; Simmons RL
    Cancer; 1979 Apr; 43(4):1297-303. PubMed ID: 445331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical adjuvant immunotherapy for colorectal cancer.
    Enker WE; Jacobitz JL; Craft K; Wissler RW
    J Surg Oncol; 1978; 10(5):389-97. PubMed ID: 732327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunotherapy of advanced human cancer with neuraminidase.
    Ngu VA; Osunkoya BO; Ajayi OO; Khwaja MS
    Niger Med J; 1973 Jan; 3(1):15-9. PubMed ID: 4805217
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacillus calmette-guerin (BCG) adjuvant therapy in stage D prostate cancer.
    Guinan P; Toronchi E; Shaw M; Crispin R; Sharifi R
    Urology; 1982 Oct; 20(4):401-3. PubMed ID: 6755855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic sarcoma. Combined surgical and immunotherapeutic approach. Neuraminidase treated tumor cells as tumor vaccine.
    Gunnarsson A; McKhann CF; Simmons RL; Grage TB
    Minn Med; 1974 Jul; 57(7):558-61. PubMed ID: 4845897
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant immunotherapy (BCG) in stage D prostate cancer.
    Guinan PD; John T; Baumgartner G; Sundar B; Ablin RJ
    Am J Clin Oncol; 1982 Feb; 5(1):65-8. PubMed ID: 7081139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and chemotherapy in children with neuroblastoma.
    Nesbit ME; Kersey J; Finklestein J; Weiner J; Simmons R
    J Natl Cancer Inst; 1976 Sep; 57(3):717-20. PubMed ID: 978774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumors.
    Sedlacek HH; Bengelsdorff KH; Hagmayer G; Seiler FR
    Int J Immunopharmacol; 1987; 9(7):841-50. PubMed ID: 3429076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful use of adjuvant immunotherapy in resected colorectal tumors].
    Würschmidt F; Baumann M
    Strahlenther Onkol; 1995 Mar; 171(3):175-6. PubMed ID: 7709334
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.
    Cunningham TJ; Antemann R; Paonessa D; Sponzo RW; Steiner D
    Ann N Y Acad Sci; 1976; 277(00):339-44. PubMed ID: 1069553
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunisation of colorectal cancer patients with autologous tumour cells.
    Diederichsen AC; Stenholm AC; Kronborg O; Fenger C; Jensenius JC; Zeuthen J; Kristensen T; Christensen PB
    Oncol Rep; 1998; 5(4):823-6. PubMed ID: 9625825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
    Taylor SG; Sisson GA; Bytell DE; Raynor WJ
    Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
    Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy in colorectal cancer.
    Vermorken JB
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.